China Resources Pharmaceutical Group Limited Stock
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.800 HKD | -1.84% |
|
+1.91% | +7.87% |
| 06-01 | China Resources Pharma Unit Gets China Acceptance for 5 Billion Yuan Bond Issue; Shares Climb 3% | MT |
| 04-28 | China Resources Pharmaceutical Unit Sells 1.4 Billion Yuan Bonds | MT |
| Market Cap | 30.16B 3.85B 3.33B 3.07B 2.87B 5.36B 367B 5.48B 36.48B 14.15B 178B 14.44B 14.13B 617B | P/E Ratio 2026 * |
6.12x | P/E Ratio 2027 * | 5.73x |
|---|---|---|---|---|---|
| Enterprise Value | 83.51B 10.66B 9.22B 8.5B 7.95B 14.84B 1,015B 15.18B 101B 39.17B 492B 40B 39.14B 1,710B | EV / Sales 2026 * |
0.26x | EV / Sales 2027 * | 0.23x |
| Free-Float |
28.62% | Yield 2026 * |
4.28% | Yield 2027 * | 4.67% |
| 1 day | -1.84% | ||
| 1 week | +1.91% | ||
| Current month | +2.78% | ||
| 1 month | -6.80% | ||
| 3 months | +6.90% | ||
| 6 months | +5.26% | ||
| Current year | +7.87% |
| 1 week | 4.67 |  | 4.96 |
| 1 month | 4.61 | | 5.25 |
| Current year | 4.34 | | 6.53 |
| 1 year | 4.34 | | 6.53 |
| 3 years | 4.34 | | 7.62 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 26/08/2025 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 13/06/2023 |
Wing Yi Wan
SEC | Corporate Secretary | - | 15/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 59 | 01/06/2016 |
Ke Jian Zhang
BRD | Director/Board Member | 70 | 20/06/2016 |
Xiao Song Bai
CHM | Chairman | 54 | 29/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/04/20 | Other | Chief Executive Officer | 200,000 | 0.0032% | ||
| 31/03/20 | Other | Chief Executive Officer | 100,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.84% | +1.91% | -10.61% | -36.68% | 3.92B | |
| +2.62% | +3.28% | +43.73% | +160.99% | 1,013B | |
| +0.69% | +4.99% | +54.30% | +49.82% | 574B | |
| +0.44% | +0.26% | +17.77% | +63.75% | 397B | |
| -0.37% | +4.97% | +21.24% | +15.95% | 324B | |
| +0.85% | +0.18% | +24.50% | +14.78% | 280B | |
| +2.10% | +4.92% | +25.30% | +33.80% | 273B | |
| +3.41% | +0.93% | +19.53% | +60.48% | 182B | |
| -0.19% | -0.46% | -45.32% | -48.35% | 194B | |
| +3.86% | -2.59% | +15.13% | +61.62% | 151B | |
| Average | +1.14% | +2.76% | +16.56% | +37.62% | 339.26B | |
| Weighted average by Cap. | +1.46% | +3.99% | +29.54% | +72.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 325B 41.43B 35.86B 33.06B 30.93B 57.71B 3,947B 59.01B 393B 152B 1,912B 156B 152B 6,648B | 341B 43.56B 37.7B 34.75B 32.51B 60.67B 4,150B 62.03B 413B 160B 2,010B 164B 160B 6,989B |
| Net income | 4.83B 616M 533M 491M 460M 858M 58.66B 877M 5.84B 2.26B 28.41B 2.31B 2.26B 98.8B | 5.22B 666M 577M 532M 497M 928M 63.48B 949M 6.32B 2.45B 30.74B 2.5B 2.45B 107B |
| Net Debt | 53.35B 6.81B 5.89B 5.43B 5.08B 9.48B 649B 9.7B 64.53B 25.03B 314B 25.56B 25.01B 1,092B | 47.96B 6.12B 5.3B 4.88B 4.57B 8.52B 583B 8.72B 58.01B 22.5B 282B 22.97B 22.48B 982B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/06/26 | 4.800 $ | -1.84% | 11,219,848 |
| 10/06/26 | 4.890 $ | +3.60% | 11,173,500 |
| 09/06/26 | 4.720 $ | -0.63% | 11,794,100 |
| 08/06/26 | 4.750 $ | +0.42% | 7,778,403 |
| 05/06/26 | 4.730 $ | -0.21% | 10,650,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition